BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Independent Stock Specific Research

IPAR: Fragrance of a Price Target Increase

IPAR: 2024 in the Spotlight, Target Now $172

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Equity Bottom-Up

<ul>
<li>IPAR has added Lacoste to its portfolio of fragrance licenses and should lead to incremental growth in 2024.</li>
<li>Lacoste, like IPAR’s other major licenses, is a well-established brand that is likely to immediately contribute to sales and earnings growth when in 2024</li>
<li>Heading into the holiday shopping season of 2022, fragrance was proving as a high demand category from consumers</li>
</ul>


IPAR has added Lacoste to its portfolio of fragrance licenses and should lead to incremental growth in 2024.
Lacoste, like IPAR’s other major licenses, is a well-established brand that is likely to immediately contribute to sales and earnings growth when in 2024
Heading into the holiday shopping season of 2022, fragrance was proving as a high demand category from consumers


Inter Parfums

IPAR: Catalysts for Further Growth